Related Experiment Video
Updated: Jul 15, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
Published on: April 29, 2014
Renal cell carcinoma
W Kimryn Rathmell1, Caroline A Martz, Brian I Rini
1University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599-7295, USA. rathmell@med.unc.edu
Purpose Of Review:
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or response to treatment.
Recent Findings:
Advances in our understanding of the molecular biology underpinning renal cell carcinoma and the introduction of new targeted therapeutics with benefit in the metastatic setting have had a major impact on the treatment of this disease.
Summary:
The management of metastatic renal cell carcinoma has undergone a dramatic evolution in the past year, marked by the approval of two drugs by the US Food and Drug Administration. These drugs have demonstrated improved progression-free survival as well as potentially improved overall survival for patients with metastatic disease. These groundbreaking treatment strategies have fueled a surge in translational studies expanding our knowledge of the molecular biology of renal cell carcinoma.
Insights
Recent advances in renal cell carcinoma (RCC) treatment include new targeted therapies and antiangiogenic agents. These innovations improve survival outcomes for metastatic disease and drive further research into RCC
Area of Science:
- Oncology
- Translational Research
Background:
- Renal cell carcinoma (RCC) is a complex malignancy with evolving treatment paradigms.
- Understanding the molecular underpinnings of RCC is crucial for developing effective therapies.
Purpose of the Study:
- To review recent advancements in the biology and treatment of renal cell carcinoma.
- To highlight the expanded use of antiangiogenic agents and other novel drug mechanisms.
- To report on emerging biomarkers for prognostic indicators in RCC.
Main Methods:
- Literature review of recent contributions to renal cell carcinoma research.
- Analysis of emerging targeted therapeutics and their impact on metastatic disease.
- Investigation of novel drug mechanisms and prognostic biomarkers.
Main Results:
- Significant progress in understanding RCC molecular biology.
- Introduction of new targeted therapeutics benefiting patients with metastatic RCC.
- Identification of promising biomarkers for survival and treatment response prediction.
Conclusions:
- The management of metastatic renal cell carcinoma has been revolutionized by recent drug approvals.
- New treatments demonstrate improved progression-free and overall survival.
- These advancements stimulate further translational studies in RCC.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Chronic Kidney Disease I: Introduction
Urinary Tract Calculi I: Introduction
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Nephrons